Orbactiv
Active Ingredient(s): Oritavancin DiphosphateFDA Approved: * August 6, 2014
Pharm Company: * MEDICINES CO
Category: Antibiotics
Oritavancin, sold under the brand name Orbactiv among others, is a semisynthetic glycopeptide antibiotic medication for the treatment of serious Gram-positive bacterial infections. Its chemical structure as a lipoglycopeptide is similar to vancomycin.[4] The U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have approved oritavancin for treatment of acute bacterial skin and skin structure infections.[5][3] Conten... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.Dosage List
Orbactiv 400 mg Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 70842-140
Labeler:
Melinta Therapeutics, Inc.
Related Brands
Drugs with the same active ingredients